A murine model of inflammation-induced cerebral microbleeds

Rachita K Sumbria1,2, Mher Mahoney Grigoryan2, Vitaly Vasilevko3

  • 1Department of Biopharmaceutical Sciences, School of Pharmacy, Keck Graduate Institute, Claremont, CA, USA.

Abstract

Insights

Inflammation can cause cerebral microhemorrhages (CMH). Lipopolysaccharide (LPS) injection in mice rapidly induced CMH, suggesting this model is useful for studying inflammation-related brain bleeds.

Area of Science:

  • Neuroscience
  • Pathology
  • Immunology

Background:

  • Cerebral microhemorrhages (CMH) are brain bleeds linked to aging, sepsis, and neurodegeneration.
  • Existing CMH models involve amyloid, hypoxia, or hypertension.
  • Inflammation is a common factor in CMH pathologies, with recent studies linking systemic inflammation to CMH.

Purpose of the Study:

  • To investigate if inflammation induces CMH development.
  • To establish lipopolysaccharide (LPS)-induced CMH as a relevant animal model for studying cerebral microbleeds.

Main Methods:

  • Adult C57BL/6 mice received LPS or saline injections.
  • Brains were analyzed at 2 and 7 days post-injection using Hematoxylin and eosin (H&E) and Prussian blue (PB) staining.
  • Immunohistochemistry, MRI, and fluorescence microscopy assessed blood-brain barrier disruption, neuroinflammation, and CMH presence.

Main Results:

  • LPS administration led to H&E-positive CMH at 2 days and PB-positive CMH at 7 days.
  • LPS-induced CMH were dose-dependent and primarily located in the cerebellum, sub-cortex, and cortex.
  • CMH development correlated with endothelium activation, blood-brain barrier disruption, and neuroinflammation.

Conclusions:

  • Lipopolysaccharide (LPS) rapidly and robustly induced both acute and sub-acute CMH in mice.
  • The LPS-induced model is suitable for studying inflammation-driven cerebral microhemorrhages.

Related Concept Videos